The Skin–Mood Axis in Midlife: Neuro-Immuno-Endocrine Cross-Talk in Perimenopausal and Menopausal Aesthetic Dermatology

BACKGROUND Perimenopause and menopause may alter skin quality, repair capacity, sleep, mood, self-perception, and aesthetic motivation, yet midlife aesthetic aging is often framed primarily around estrogen and collagen loss. OBJECTIVE To propose a midlife skin–mood axis that integrates cutaneous biology, neuroendocrine signaling, immune activity, and psychosocial experience in perimenopausal and menopausal aesthetic dermatology. MATERIALS AND METHODS This narrative review synthesizes evidence regarding menopausal hormonal change, barrier and extracellular matrix remodeling, stress and sleep physiology, oxytocin-related signaling, body image, observer perception, and aesthetic motivation. RESULTS Midlife skin concerns may reflect interactions among reduced barrier resilience, altered repair capacity, neuroendocrine stress pathways, and changes in self-perception rather than isolated tissue aging. These relationships may influence tissue readiness, consultation goals, recovery counseling, patient-reported outcomes, and treatment satisfaction. CONCLUSION Recognizing the skin–mood axis may help aesthetic dermatologists individualize consultation, sequence treatments around tissue quality and recovery capacity, and align procedural choices with patient motivation and realistic patient-centered outcomes.